Fractyl Health, Inc. Increase Decrease In Operating Lease Liability
Fractyl Health, Inc. (GUTS) reported Increase Decrease In Operating Lease Liability of -$770.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-10
- Fractyl Health, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$391.00K.
- Fractyl Health, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$379.00K.
- Fractyl Health, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$355.00K.
- Fractyl Health, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$318.00K.
- Fractyl Health, Inc. increase decrease in operating lease liability for fiscal 2025 was -$1.28M, a 216.39% decline from fiscal 2024.
- Fractyl Health, Inc. increase decrease in operating lease liability for fiscal 2024 was $1.10M, a 95.03% increase from fiscal 2023.
- Fractyl Health, Inc. increase decrease in operating lease liability for fiscal 2023 was $563.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$391.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$770.00K 10-Q · filed 2026-08-10 | -$1.13M derived: sum of 3 quarters · filed 2026-08-10 | -$1.44M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$379.00K 10-Q · filed 2026-05-12 | -$734.00K derived: sum of 2 quarters · filed 2026-05-12 | -$1.05M derived: sum of 3 quarters · filed 2026-05-12 | -$1.36M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$355.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$673.00K derived: sum of 2 quarters · filed 2026-03-24 | -$980.00K derived: sum of 3 quarters · filed 2026-08-10 | -$1.28M 10-K · filed 2026-03-24 |
| 2025-09-30 | -$318.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$625.00K derived: sum of 2 quarters · filed 2026-08-10 | -$923.00K 10-Q · filed 2025-11-12 | -$1.20M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$307.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$605.00K 10-Q · filed 2026-08-10 | -$881.00K derived: sum of 3 quarters · filed 2026-08-10 | -$1.12M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$298.00K 10-Q · filed 2026-05-12 | -$574.00K derived: sum of 2 quarters · filed 2026-05-12 | -$817.00K derived: sum of 3 quarters · filed 2026-05-12 | $201.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$276.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$519.00K derived: sum of 2 quarters · filed 2026-03-24 | $499.00K derived: sum of 3 quarters · filed 2026-03-24 | $1.10M 10-K · filed 2026-03-24 |
| 2024-09-30 | -$243.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $775.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.37M 10-Q · filed 2025-11-12 | $2.18M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.62M 10-Q · filed 2025-08-12 | $2.42M derived: sum of 3 quarters · filed 2025-08-12 | $2.30M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $599.00K 10-Q · filed 2025-05-13 | $1.40M derived: sum of 2 quarters · filed 2025-05-13 | $1.28M derived: sum of 3 quarters · filed 2025-05-13 | $1.38M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $804.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $681.00K derived: sum of 2 quarters · filed 2025-03-03 | $785.00K derived: sum of 3 quarters · filed 2025-03-03 | $563.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | -$123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$19.00K derived: sum of 2 quarters · filed 2024-11-12 | -$241.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$118.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$222.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |